Skip to content

A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease

A Phase III, Open-Label, Non-Randomized, International, Multicenter Trial to Evaluate the Efficacy and Safety of CARDIOLITE® Myocardial Perfusion Imaging in Pediatric Subjects With Kawasaki Disease

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00162032
Enrollment
445
Registered
2005-09-13
Start date
2005-08-31
Completion date
2010-12-31
Last updated
2019-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kawasaki Disease

Brief summary

Determine the predictive value of CARDIOLITE® rest and stress myocardial perfusion imaging (MPI) to define a pediatric population with Kawasaki Disease (KD) at high and low risk of developing cardiac events.

Detailed description

The purpose of this clinical research study is to determine how well CARDIOLITE® rest and stress myocardial (heart) imaging can define the pediatric Kawasaki disease (KD) population into high and low risk categories of developing cardiac (heart) events (complications) from 1 year through 3 years after image completion. The safety of CARDIOLITE® rest and stress heart imaging will also be studied.

Interventions

Sestamibi

Sponsors

Lantheus Medical Imaging
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
4 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* Males or females between 4 and 16 * Meet the epidemiological definition of Kawasaki Disease or have a diagnosis of incomplete KD, including evidence of coronary artery disease as determined by their physician. * Be able to exercise adequately to achieve 85% age predicted maximum heart rate

Exclusion criteria

* Terminal illness where expected survival is \< 6 months

Design outcomes

Primary

MeasureTime frameDescription
Determine the Predictive Value of Cardiolite® Rest and Stress MPI to Define Pediatric Populations With Kawasaki Disease at High and Low Risk of Developing Cardiac Events.3 yearsThe proportion of all patients who experienced cardiac events among patients with abnormal (SSS \>=4, high risk) and normal (SSS \<4, low risk) Cardiolite MPI scans during the follow-up period. A log-rank statistic (2-sided, alpha = 0.05) was computed to compare cardiac event-free survival in the high risk and low risk groups. The cardiac event rate is the cumulative event rate based on a Kaplan-Meier estimate conditional on the SPECT MPI score result.

Secondary

MeasureTime frameDescription
Estimate the Performance of Cardiolite® Rest and Stress MPI for the Detection of Myocardial Ischemia in Adolescents and Children Versus Coronary Angiography6 monthsSensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of myocardial perfusion imaging (MPI) for the diagnosis of ischemic heart disease (IHD) relative to coronary angiography. Coronary stenoses of ≥ 50% were classified as disease. SSS \> 4 in MPI was classified as positive for IHD.
Incidence of Hard Cardiac Events3 yearsExamine the incidence of hard cardiac events (myocardial infarction \[MI\] or cardiac death) in KD subjects with positive and negative MPI scans.
Estimate the Performance of Cardiolite® Rest and Stress MPI for the Detection of Myocardial Ischemia in the Left Anterior Descending (LAD) Artery in Adolescents and Children Versus Coronary Angiography24 hoursSensitivity, specificity, PPV, and NPV of SDS for myocardial perfusion corresponding to the left anterior descending (LAD) for the diagnosis of IHD in the distribution of the left anterior descending (LAD) artery relative to coronary angiography based diagnosis were determined. Coronary stenoses of ≥ 50% for arteries associated with LAD territories were classified as LAD disease. SDS LAD \> 1 was classified as positive for IHD for the LAD distribution.
Predictive Value of Cardiolite For Cardiac Events6 monthsDetermine the incidence of cardiac events occurring over a 6 month follow up period in pediatric subjects with normal myocardial perfusion scans.

Countries

Brazil, Canada, Philippines, South Korea, Taiwan, Thailand, United States

Participant flow

Participants by arm

ArmCount
Children (Ages 4-11)
Arm A children 4-11 years of age
329
Adolescents (Ages 12-16)
Arm B children 12-16 years of age
116
Total445

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up42
Overall StudyReason not specified10

Baseline characteristics

CharacteristicChildren (Ages 4-11)Adolescents (Ages 12-16)Total
Age, Categorical
<=18 years
329 Participants116 Participants445 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Continuous7.7 years
STANDARD_DEVIATION 2.16
13.6 years
STANDARD_DEVIATION 1.31
9.0 years
STANDARD_DEVIATION 3.27
Region of Enrollment
Brazil
34 participants5 participants39 participants
Region of Enrollment
Canada
18 participants17 participants35 participants
Region of Enrollment
Korea, Republic of
43 participants10 participants53 participants
Region of Enrollment
Philippines
33 participants8 participants41 participants
Region of Enrollment
Singapore
6 participants4 participants10 participants
Region of Enrollment
Taiwan
85 participants27 participants112 participants
Region of Enrollment
Thailand
46 participants6 participants52 participants
Region of Enrollment
United States
64 participants39 participants103 participants
Sex: Female, Male
Female
104 Participants40 Participants144 Participants
Sex: Female, Male
Male
225 Participants76 Participants301 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
8 / 3295 / 116
serious
Total, serious adverse events
1 / 3290 / 116

Outcome results

Primary

Determine the Predictive Value of Cardiolite® Rest and Stress MPI to Define Pediatric Populations With Kawasaki Disease at High and Low Risk of Developing Cardiac Events.

The proportion of all patients who experienced cardiac events among patients with abnormal (SSS \>=4, high risk) and normal (SSS \<4, low risk) Cardiolite MPI scans during the follow-up period. A log-rank statistic (2-sided, alpha = 0.05) was computed to compare cardiac event-free survival in the high risk and low risk groups. The cardiac event rate is the cumulative event rate based on a Kaplan-Meier estimate conditional on the SPECT MPI score result.

Time frame: 3 years

Population: Had SPECT Myocardial perfusion imaging tests and experienced a cardiac event

ArmMeasureValue (NUMBER)
Children (4 -11 Years) NormalDetermine the Predictive Value of Cardiolite® Rest and Stress MPI to Define Pediatric Populations With Kawasaki Disease at High and Low Risk of Developing Cardiac Events.0.041 proportion of participants
Adolescents (12-16 Years) NormalDetermine the Predictive Value of Cardiolite® Rest and Stress MPI to Define Pediatric Populations With Kawasaki Disease at High and Low Risk of Developing Cardiac Events.0.033 proportion of participants
Children (4-11 Years) AbnormalDetermine the Predictive Value of Cardiolite® Rest and Stress MPI to Define Pediatric Populations With Kawasaki Disease at High and Low Risk of Developing Cardiac Events.0.115 proportion of participants
Adolescents (12-16 Years) AbnormalDetermine the Predictive Value of Cardiolite® Rest and Stress MPI to Define Pediatric Populations With Kawasaki Disease at High and Low Risk of Developing Cardiac Events.0.233 proportion of participants
Secondary

Estimate the Performance of Cardiolite® Rest and Stress MPI for the Detection of Myocardial Ischemia in Adolescents and Children Versus Coronary Angiography

Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of myocardial perfusion imaging (MPI) for the diagnosis of ischemic heart disease (IHD) relative to coronary angiography. Coronary stenoses of ≥ 50% were classified as disease. SSS \> 4 in MPI was classified as positive for IHD.

Time frame: 6 months

Population: Per-protocol population of pooled adolescents and children who underwent coronary angiography

ArmMeasureGroupValue (NUMBER)
Children (4 -11 Years) NormalEstimate the Performance of Cardiolite® Rest and Stress MPI for the Detection of Myocardial Ischemia in Adolescents and Children Versus Coronary AngiographySensitivity0.35 proportion
Children (4 -11 Years) NormalEstimate the Performance of Cardiolite® Rest and Stress MPI for the Detection of Myocardial Ischemia in Adolescents and Children Versus Coronary AngiographySpecificity0.62 proportion
Children (4 -11 Years) NormalEstimate the Performance of Cardiolite® Rest and Stress MPI for the Detection of Myocardial Ischemia in Adolescents and Children Versus Coronary AngiographyPositive Predictive Value0.21 proportion
Children (4 -11 Years) NormalEstimate the Performance of Cardiolite® Rest and Stress MPI for the Detection of Myocardial Ischemia in Adolescents and Children Versus Coronary AngiographyNegative Predictive Value0.77 proportion
Secondary

Estimate the Performance of Cardiolite® Rest and Stress MPI for the Detection of Myocardial Ischemia in the Left Anterior Descending (LAD) Artery in Adolescents and Children Versus Coronary Angiography

Sensitivity, specificity, PPV, and NPV of SDS for myocardial perfusion corresponding to the left anterior descending (LAD) for the diagnosis of IHD in the distribution of the left anterior descending (LAD) artery relative to coronary angiography based diagnosis were determined. Coronary stenoses of ≥ 50% for arteries associated with LAD territories were classified as LAD disease. SDS LAD \> 1 was classified as positive for IHD for the LAD distribution.

Time frame: 24 hours

ArmMeasureGroupValue (NUMBER)
Children (4 -11 Years) NormalEstimate the Performance of Cardiolite® Rest and Stress MPI for the Detection of Myocardial Ischemia in the Left Anterior Descending (LAD) Artery in Adolescents and Children Versus Coronary AngiographySensitivity.25 proportion
Children (4 -11 Years) NormalEstimate the Performance of Cardiolite® Rest and Stress MPI for the Detection of Myocardial Ischemia in the Left Anterior Descending (LAD) Artery in Adolescents and Children Versus Coronary AngiographySpecificity0.76 proportion
Children (4 -11 Years) NormalEstimate the Performance of Cardiolite® Rest and Stress MPI for the Detection of Myocardial Ischemia in the Left Anterior Descending (LAD) Artery in Adolescents and Children Versus Coronary AngiographyPositive Predictive Value0.14 proportion
Children (4 -11 Years) NormalEstimate the Performance of Cardiolite® Rest and Stress MPI for the Detection of Myocardial Ischemia in the Left Anterior Descending (LAD) Artery in Adolescents and Children Versus Coronary AngiographyNegative Predictive Value0.86 proportion
Adolescents (12-16 Years) NormalEstimate the Performance of Cardiolite® Rest and Stress MPI for the Detection of Myocardial Ischemia in the Left Anterior Descending (LAD) Artery in Adolescents and Children Versus Coronary AngiographyNegative Predictive Value0.82 proportion
Adolescents (12-16 Years) NormalEstimate the Performance of Cardiolite® Rest and Stress MPI for the Detection of Myocardial Ischemia in the Left Anterior Descending (LAD) Artery in Adolescents and Children Versus Coronary AngiographySensitivity0.00 proportion
Adolescents (12-16 Years) NormalEstimate the Performance of Cardiolite® Rest and Stress MPI for the Detection of Myocardial Ischemia in the Left Anterior Descending (LAD) Artery in Adolescents and Children Versus Coronary AngiographyPositive Predictive Value0.00 proportion
Adolescents (12-16 Years) NormalEstimate the Performance of Cardiolite® Rest and Stress MPI for the Detection of Myocardial Ischemia in the Left Anterior Descending (LAD) Artery in Adolescents and Children Versus Coronary AngiographySpecificity0.74 proportion
Secondary

Incidence of Hard Cardiac Events

Examine the incidence of hard cardiac events (myocardial infarction \[MI\] or cardiac death) in KD subjects with positive and negative MPI scans.

Time frame: 3 years

Population: All subjects who had undergone stress cardiac MPI studies

ArmMeasureValue (NUMBER)
Children (4 -11 Years) NormalIncidence of Hard Cardiac Events0 participants
Adolescents (12-16 Years) NormalIncidence of Hard Cardiac Events0 participants
Children (4-11 Years) AbnormalIncidence of Hard Cardiac Events0 participants
Adolescents (12-16 Years) AbnormalIncidence of Hard Cardiac Events0 participants
Secondary

Predictive Value of Cardiolite For Cardiac Events

Determine the incidence of cardiac events occurring over a 6 month follow up period in pediatric subjects with normal myocardial perfusion scans.

Time frame: 6 months

Population: Efficacy Evaluable Population

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Children (4 -11 Years) NormalPredictive Value of Cardiolite For Cardiac Events3 Participants
Adolescents (12-16 Years) NormalPredictive Value of Cardiolite For Cardiac Events1 Participants
Children (4-11 Years) AbnormalPredictive Value of Cardiolite For Cardiac Events3 Participants
Adolescents (12-16 Years) AbnormalPredictive Value of Cardiolite For Cardiac Events2 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026